Profile
XBIT VRTX REGN VRNA ARGX ALNY
Company Name XBiotech Inc. Vertex Pharmaceuticals Incorporated Regeneron Pharmaceuticals, Inc. Verona Pharma plc argenx SE Alnylam Pharmaceuticals, Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology
Market Cap $75.61M $122.53B $81.62B $72.68B $50.22B $43.35B
Employees 0.09K 6.10K 15.16K 0.21K 1.60K 2.23K
CEO Sushma Shivaswamy Reshma Kewalramani Leonard S. Schleifer David S. Zaccardelli Timothy Van Hauwermeiren Yvonne L. Greenstreet
Ratings
XBIT VRTX REGN VRNA ARGX ALNY
Quant Rating Score 2 4 4 1 4 3
Quant Rating Sell Buy Buy Strong Sell Buy Neutral
Trading
XBIT VRTX REGN VRNA ARGX ALNY
Last Close $2.47 $434.02 $704.31 $106.91 $929.61 $460.54
High 52 $7.61 $513.76 $788 $106.91 $929.61 $491.09
Low 52 $2.12 $366.54 $482.92 $37.86 $532.27 $224.58
Price vs. 52 Week High -67.54 % -15.52 % -10.62 % 0 % 0 % -6.22 %
Price vs. 52 Week Low 16.51 % 18.41 % 45.84 % 182.38 % 74.65 % 105.07 %
Total Return
XBIT VRTX REGN VRNA ARGX ALNY
1 Month Return -0.8 % 4.13 % 21.84 % 0 % 10.19 % -4.39 %
3 Month Return -22.81 % 11.32 % 22.74 % 1.06 % 40.57 % 0.8 %
6 Month Return -18.75 % -1.06 % 18.51 % 49.92 % 64.35 % 61.42 %
9 Month Return -18.48 % -6.08 % 3.57 % 66.4 % 45.48 % 84.22 %
YTD Return -37.47 % 7.78 % -1.13 % 130.21 % 51.16 % 95.72 %
1 Year Return -62.97 % -3.12 % -5.41 % 180.68 % 61.8 % 96.59 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
XBIT VRTX REGN VRNA ARGX ALNY
Dividend Yield Percentage (TTM) - - 0.45 % - - -
Dividend Paid and Capex Coverage Ration (TTM) -69.35 % 9.76 % 3.92 % -147.93 % 65.28 % 5.97 %
Dividend Per Share (TTM) - - 3.52 % - - -
Payout Ratio (TTM) - - 8.22 % - - -
Growth
XBIT VRTX REGN VRNA ARGX ALNY
Asset Growth -12.14 % 7.41 % 53.91 % 10.71 %
Gross Profit Growth - 1.16 % - 26.81 %
Revenue Growth - 0.99 % - 22.97 %
Revenue 3 Year -100 % 20.64 % -15.89 % 147.1 %
Revenue 5 Year - 73.64 % - 775.72 %
Revenue 10 Year - 285.02 % - 2487.4 %
EBIT Growth -55.29 % 9.09 % -131.37 % 24.59 %
Net Income Growth -56.9 % 2.09 % -224.78 % 36.82 %
Net Income 3 Yeari Growth Per Share -118.23 % 6.32 % -148.34 % 69.73 %
Net Income 5 Yeari Growth Per Share -107.37 % 31.91 % 25.82 % 73.13 %
Net Income 10 Yeari Growth Per Share -84.68 % 680.22 % -35.51 % 55.09 %
Operating Income Growth -13.23 % -7.46 % -133.02 % 37.31 %
Operating Cash Flow Growth (CFG) -65.36 % - -143.33 % -107.98 %
Operating 3 Year CFG -143.98 % -100 % -170.73 % 98.8 %
Operating 5 Year CFG -116.68 % -100 % 54.81 % 97.44 %
Operating 10 Year CFG -175.55 % -100 % 40.15 % 97.08 %
EPS Growth -55.56 % 5.31 % -214.81 % 38.07 %
EPS Diluted Growth -55.56 % 8.19 % -208.93 % 38.07 %
Book Value Per Share -17.11 % 32.88 % -22.82 % 129.75 %
Share Holder 3 Year Equity Growth Per Share -33.27 % 41.21 % 1.82 % -89.42 %
Share Holder 5 Year Equity Growth Per Share -69.16 % 191.63 % -24.45 % -96.01 %
Share Holder 10 Year Equity Growth Per Share 221.5 % 842.11 % -71.86 % -95.83 %
Dividend Per Share Growth - - - -
Dividend 3 Year Growth Per Share -100 % - - -
Dividend 5 Year Growth Per Share - - - -
Dividend 10 Year Growth Per Share - - - -
Debt Growth - 0.06 % 139.05 % 110.16 %
Free Cash Flow Growth -69.05 % - -144.48 % -201.54 %
Updated On 31 Dec 2024 31 Dec 2025 31 Dec 2024 31 Dec 2024
Profitability
XBIT VRTX REGN VRNA ARGX ALNY
Gross Profit Margin TTM - 86.28 % 86.27 % 95.15 % 65.82 % 83.99 %
Return on Assets TTM -16.91 % 14.78 % 11.11 % -11.01 % 15.06 % 0.9 %
Return on Equity TTM -16.73 % 21.81 % 14.83 % -30.05 % 18.96 % 26.13 %
Return on Capital Employed TTM -20.54 % 19.59 % 10.3 % -8.31 % 5.04 % 8.03 %
Net Income Per EBT TTM 100.41 % 82.61 % 86.12 % 111.64 % 237.3 % -136.38 %
EBT Per Ebit TTM 83.73 % 111.4 % 146.19 % 130.36 % 147.38 % -12.07 %
EBIT Per Revenue TTM - 34.06 % 24.95 % -25.86 % 13.47 % 8.25 %
Cash Flow To Debt Ratio TTM - 202.64 % 184 % -29.66 % 932.29 % 9.59 %
Receivables Turnover TTM - 6.02 2.5 1.93 1.91 3.33
Payables Turnover TTM 0.41 0.4 2.1 2.37 0.9 4.37
Inventory Turnover TTM - 0.99 0.62 0.94 2.26 6.82
Fixed Asset Turnover TTM - 388.59 % 280.11 % 6536.22 % 5009.77 % 463.12 %
Asset Turnover TTM - 47.15 % 35.36 % 29.27 % 31.97 % 66.16 %
Operating Cash Flow Per Share TTM -0.77 14.55 48.39 -0.85 5.67 2.02
Free Cash Flow Per Share TTM -0.78 13.06 39.66 -0.85 5.58 1.68
Cash Per Share TTM 483.36 % 2459.7 % 8362.68 % 511.43 % 5536.58 % 2072.79 %
Operating Cash Flow Sales Ratio TTM - 31.71 % 34.71 % -43.23 % 17.54 % 8.28 %
Free Cash Flow Operating Cash Flow Ratio TTM 101.44 % 89.76 % 81.96 % 100.75 % 98.47 % 83.26 %
Cash Flow Coverage Ratios TTM - 202.64 % 184 % -29.66 % 932.29 % 9.59 %
Price To Free Cash Flows Ratio TTM -3.17 36.72 20 -995.27 127.92 195.85
Price To Operating Cash Flows Ratio TTM -3.22 32.86 16.23 -126.33 144.41 162.25
Price Cash Flow Ratio TTM -3.22 32.86 16.23 -126.33 144.41 162.25
Income Statement (TTM)
XBIT VRTX REGN VRNA ARGX ALNY
Revenue $0B $11.02B $14.34B $0.03B $2.19B $2.25B
Gross Profit $0B $9.49B $12.24B $0.03B $1.96B $1.92B
Gross Profit Ratio 0% 86.11% 85.35% 93.89% 89.62% 85.62%
EBITDA $-0.04B $0.49B $5.82B $-0.12B $0.11B $-0.18B
Net Income $-0.04B $-0.54B $4.5B $-0.14B $0.83B $-0.28B
EPS Diluted -1.26 -2.08 41.48 -1.73 12.78 -2.18
Balance Sheet (MRQ)
XBIT VRTX REGN VRNA ARGX ALNY
Long Term Debt $0B $1.66B $2.71B $0.12B $0.03B $2.59B
Total Liabilities $0.02B $6.12B $9.3B $0.27B $0.7B $4.17B
Total Equity $0.18B $16.41B $31.26B $0.2B $5.5B $0.07B
Total Investments $0B $6.65B $15.75B $0.02B $1.93B $1.73B
Total Debt $0.01B $1.75B $2.71B $0.12B $0.04B $2.74B
Total Assets $0.2B $22.53B $40.56B $0.47B $6.2B $4.24B
Cash Flow Statement (TTM)
XBIT VRTX REGN VRNA ARGX ALNY
Net Income $-0.04B $-0.54B $4.5B $-0.17B $0.83B $-0.28B
Inventory $0B $-0.52B $-0.28B $-0.01B $-0.1B $0.01B
Dividends Paid $0B $0B $-0.37B $0B $0B $0B
Operating Cash Flow $-0.03B $-0.49B $4.98B $-0.12B $-0.08B $-0.01B
Capital Expenditure $-0B $-0.3B $-0.9B $-0B $-0.07B $-0.03B
Related Stocks
Ticker Name Price
AADI Aadi Bioscience, Inc. 2.05
AAPG 24.58
AARD Aardvark Therapeutics, Inc. Common Stock 12.71
ABCL AbCellera Biologics Inc. 3.135
ABCM Abcam plc 23.99
ABEO Abeona Therapeutics Inc. 5.05
ABIO ARCA biopharma, Inc. 28.8
ABOS Acumen Pharmaceuticals, Inc. 2.565
ABPWW 0.0133
ABSI Absci Corporation 2.62
ABUS Arbutus Biopharma Corporation 4.17
ABVC ABVC BioPharma, Inc. 1.74
ABVX Abivax SA American Depositary Shares 123.055
ACAD ACADIA Pharmaceuticals Inc. 22.47
ACER Acer Therapeutics Inc. 0.6601
ACET Adicet Bio, Inc. 6.81
ACGN Aceragen, Inc. 0.3849
ACHL Achilles Therapeutics plc 1.48
ACHV Achieve Life Sciences, Inc. 4.29
ACIU AC Immune SA 3.03
ETFs With Exposure to XBIT
Ticker ETF Name Weight Percentage Price
IWM iShares Russell 2000 ETF 0.00007 264.91
VTI Vanguard Total Stock Market Index Fund 0.00002 341.49
ITOT iShares Core S&P Total U.S. Stock Market ETF 0.0001 151.485
IWN iShares Russell 2000 Value ETF 0.00018 200.48
VXF Vanguard Extended Market Index Fund 0.00057 218.255
HDG ProShares Hedge Replication ETF 0.000265603 52.7979
UWM ProShares Ultra Russell2000 0.00155512 53.94
VTHR Vanguard Russell 3000 Index Fund 0 306.2
IWC iShares Micro-Cap ETF 0.01 167.885
URTY ProShares UltraPro Russell2000 0.001244 64.825
VTWV Vanguard Russell 2000 Value Index Fund 0.0048 176.94
VTWO Vanguard Russell 2000 Index Fund 0.00224 107.12
XSU.TO iShares U.S. Small Cap Index ETF (CAD-Hedged) 0 50.12
VITNX Vanguard Institutional Total Stock Market Index Fund Institutional Shares 0.00011 115.08
VITPX Vanguard Institutional Total Stock Market Index Fund Institutional Plus Shares 0 115.06
VBAIX Vanguard Balanced Index Fund Institutional Shares 0.00006 52.59
VBIAX Vanguard Balanced Index Fund Admiral Shares 0.00006 52.59
VBINX Vanguard Balanced Index Fund Investor Shares 0 52.59
VALT ETFMG Sit Ultra Short ETF 0.34 48.52
AVUV Avantis U.S. Small Cap Value ETF 0 115.35
GERM ETFMG Treatments, Testing and Advancements ETF 0.48 19.1577
SILX ETFMG Prime 2x Daily Junior Silver Miners ETF 0.3 1.75
VTSAX Vanguard Total Stock Market Index Fund 0.00002 166.35
VIEIX Vanguard Extended Market Index Fund Institutional Shares 0.00057 166.39
VITSX Vanguard Total Stock Market Index Fund 0.00002 166.38
SWTSX Schwab Total Stock Market Index Fd Select Shs a Series of Schwab Capit 0.000325277 16.7
VEXAX Vanguard Extended Market Index Fd Admiral Shs 0.00057 166.41
JKK iShares Morningstar Small-Cap Growth ETF 0.01 307.42
JKJ iShares Morningstar Small-Cap ETF 0.01 231.193
AVSC Avantis U.S. Small Cap Equity ETF 0 65.165
DFQTX DFA U.S. Core Equity 2 Portfolio 0 46.28
VTS.AX Vanguard US Total Market Shares Index ETF 0.00002 482.09
VEMPX Vanguard Extended Market Index InstlPlus 0.00057 410.63
FESM 0.02 40.39
VSMPX Vanguard Total Stock Mkt Idx Instl Pls 0.00002 312.11
RSSL Global X Funds 0 103.83
RFLR Innovator ETFs Trust 0.01 29.76
Unlock